Inspiremd Stock Investor Sentiment

NSPR Stock  USD 3.00  0.02  0.67%   
Slightly above 51% of InspireMD's investor base is interested to short. The analysis of overall sentiment of trading InspireMD stock suggests that many investors are impartial at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

InspireMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at news.google.com         
InspireMD Now Covered by Analysts at StockNews.com - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Now Covered by Analysts at StockNews.com - Defense World
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Kester Thomas J of 11098 shares of InspireMD at 3.14 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
StockNews.com Initiates Coverage on InspireMD - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Now Covered by Analysts at StockNews.com - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Head to Head Comparison InspireMD and Fresenius SE Co. KGaA - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Research Coverage Started at StockNews.com - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Announces Distribution Agreement for CGuard EPS in Poland - Yahoo Lifestyle UK
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Research Coverage Started at StockNews.com - MarketBeat
Google News at Macroaxis
over three months ago at finance.yahoo.com         
InspireMD Announces Full Exercise of Series H Warrant Tranche forGross Proceeds of 17.9 Million
Yahoo News
over three months ago at massdevice.com         
InspireMD brings in 17.9M to support stent trial
news
over three months ago at news.google.com         
Meihua International Medical Technologies versus InspireMD Critical Contrast - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Coverage Initiated at StockNews.com - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
InspireMD Receives New Coverage from Analysts at StockNews.com - Defense World
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 61249 shares by Berman Michael of InspireMD at 1.3827 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Sight Sciences, Inc. Reports Q3 Loss, Misses Revenue Estimates
11/08/2024
2
What To Expect From InspireMD Inc Q3 2024 Earnings
11/11/2024
3
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12/2024
4
InspireMD Inc Q3 2024 Earnings Call Highlights Revenue Growth Amid Rising Costs and ...
11/13/2024
5
StockNews.com Begins Coverage on InspireMD - MarketBeat
11/18/2024
6
InspireMD Now Covered by Analysts at StockNews.com - MarketBeat
12/03/2024
7
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization ...
12/09/2024
8
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
12/12/2024

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.